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Abstract
Background: The immunologic status of a newly diagnosed HIV positive population in the era of antiretroviral
therapy in China has not been extensively evaluated. We conducted a cross-sectional survey to evaluate the CD4
counts of newly diagnosed HIV-infected persons and determine the factors influencing these counts in China.
Methods: Two thousand eight hundred and sixty-six newly diagnosed HIV-infected patients from 10 provinces in
China were selected during 2009 to 2010. Serum samples were collected to measure CD4 counts by flow
cytometry. Demographics and medical histories were recorded. Multivariate logistic regression models were used to
analyze factors associated with low CD4 count (<100 cells/mm3) at HIV diagnosis.
Results: Among the 2866 patients, 2159 (75.33%) were male. Mean age was 40 years (range: 18–86 years). The
median CD4 count at HIV diagnosis was 83 cells/mm3, 72.02% of the patients had a CD4 count that was ≤200
cells/mm3, 53.98% had CD4 counts <100 cells/mm3. The difference in CD4 counts between males and females was
not statistically significant (P=0.469). The median CD4 count differed significantly according to age (P=0.002),
province (P<0.001), ethnicity (P<0.001) and HIV transmission route (P<0.001). In multivariate logistic analysis, factors
associated with greater odds of low CD4 count at HIV diagnosis included male sex, younger age, HIV transmission
route classified as unknown transmission risk, having been diagnosed in provinces Guangxi, Henan, Heilongjiang,
Jiangxi, Shanghai and Yunnan.
Conclusions: At the time of HIV diagnosis, a large proportion of HIV-infected patients in China had an initial CD4
count that was consistent with relatively advanced disease. Low CD4 count was associated with male gender,
younger age, route of HIV transmission and geographical areas. HIV testing policy that promotes routine testing for
HIV infection is needed to facilitate earlier HIV diagnosis.
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Background
HIV/AIDS has become one of the major public health
problems in China. Although the overall prevalence of
HIV remains relatively low in China, the epidemic is
characterized by geographical disparities and a higher
prevalence reported among certain sub-groups [1]. In
November of 2003, the Chinese Ministry of Health an-
nounced a national policy of free antiretroviral treatment
(ART) to all HIV positive Chinese citizens who were in
poverty and required ART. The free ART has improved
HIV-infected patients’ quality of life, prolonged patients’
lives, and reduced the AIDS mortality rate [2,3]. Delayed
diagnosis of HIV is associated with a worse prognosis
despite ART. China has boosted its screening efforts for
HIV, with an increase in the number of persons diag-
nosed with HIV [4]. Despite the enormous attention be-
ing paid to early diagnosis and treatment of HIV/AIDS
worldwide, studies still show that most patients present
late for care [5-7].
HIV infection leads to immune system collapse, fol-
lowing a gradual destruction of CD4+T lymphocytes that
causes a severe immune suppression and consequently a
high risk of opportunistic infections. All HIV-infected
patients should have a baseline CD4 count measured at
entry into care [8]. The CD4 count is the major labora-
tory indicator of immune function in HIV-infected pa-
tients [8]. It is a useful tool to guide the initiation of
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ART and prophylaxis for opportunistic infections, and it is
the strongest predictor of subsequent disease progression
and survival [9,10]. In China, HIV diagnosis is mostly
done in severe or acute clinical circumstances, or among
high-risk groups, blood donors, or within voluntary coun-
seling and testing (VCT) facilities. In order to learn about
the immunologic status of a newly diagnosed HIV positive
population in China, we conducted a cross-sectional sur-
vey to evaluate the baseline CD4 counts of newly diag-
nosed HIV-infected persons and investigate the factors
related to low CD4 level at HIV diagnosis.
Methods
Study population
This study was part of the research content of the 12th
Five-Year infectious disease research program which was
supported by the Ministry of Science and Technology,
China. We conducted a cross-sectional survey on HIV/
AIDS in China’s HIV epidemic provinces including Shaanxi,
Xinjiang, Hunan, Guangdong, Yunnan, Heilongjiang,
Shanghai, Henan, Jiangxi, and Guangxi during 2009 to
2010. The survey subjects were newly diagnosed HIV/
AIDS patients who had not received ART. The patients
were addressed to the HIV diagnosis and management
hospitals, because they had symptoms and or risky behav-
iors. Patients aged 18 years or more at the time of enrol-
ment with documented HIV-1 infection were eligible for
this study. Only antiretroviral naïve patients were included
in the study. Being on ART was an exclusion criterion.
Antiretroviral experienced but currently untreated pa-
tients were not eligible for this study. All patients were
confirmed to be positive for HIV antibody through labora-
tory detection, and the diagnosis was in line with national
HIV/AIDS diagnostic criteria. Demographic characteris-
tics and medical histories of the patients were recorded.
Blood samples
For newly diagnosed HIVAIDS patients, two-milliliter ven-
ous blood samples were obtained from each individual at
the initial visit in order to make a CD4 count. Written in-
formed consent was obtained for all subjects; consent forms
and procedures, as well as survey protocol, were approved
by the Shanghai Public Health Clinical Center Ethics
Committee. CD4 count was measured by flow cytometry
at the clinical laboratories in each province. All the study
laboratories successfully completed a standardization and
certification program. The study doctors provided com-
prehensive care for the study patients according to the
guidelines for diagnosis and treatment of HIV/AIDS in
China before and after the blood test was done.
Data collection
Data were collected according to standardised criteria.
On enrolment, standardised data collection forms were
completed at the sites providing information from pa-
tient interview and patient case notes. Data collected on
newly identified cases included demographic informa-
tion, risk-behavior information (injection drug use, sex-
ual risk behavior, receipt of blood transfusion), and
laboratory test results. Variables of interest included
province (geographical area of HIV diagnosis), age, sex,
ethnicity, and HIV transmission route. Age was denoted
as ≤24, 25–34, 35–44, 45–54 or ≥55 years. Race/ethni-
city was designated as Han, Zhuang, Uygur or other.
HIV transmission route was categorized as sexual con-
tact (including homosexual or heterosexual, the data on
homosexual sex were not collected, sexual contact was
not designated as homosexual or heterosexual sex in this
study), blood transfusion, injection drug use, or unknown
transmission risk.
Statistical analysis
SPSS software for Windows (Version 11.5; SPSS Inc.,
Chicago, IL) was used for statistical analysis. Data were
described using median (interquartile range, IQR) and
frequencies. We performed Mann–Whitney U test or
Kruskal-Wallis H test to compare CD4 counts between
different subgroups. Multivariate logistic regression mo-
dels were used to analyze factors associated with low
CD4 count at HIV diagnosis. The fitness of the final
model was assessed with the likelihood ratio test. Low
CD4 count was defined as CD4 count <100 cells/mm3 at
HIV diagnosis. Factors included in the models were
province, sex, age, ethnicity and HIV transmission route.
All variables included in the models were determined a
priori based on epidemiological importance and bio-
logical plausibility. The statistical test was two-tailed and
performed at a level of statistical significance of 0.05.
Results
Patient characteristics
We investigated a total of 2866 newly diagnosed HIV-
infected patients from 10 provinces; 1048 patients were
from Guangxi, 529 from Yunnan, 51 from Henan, 222
from Xinjiang, 64 from Jiangxi, 197 from Guangdong, 95
from Shaanxi, 176 from Hunan, 80 from Heilongjiang,
and 404 from Shanghai. Table 1 describes the basic char-
acteristics of the study population according to province.
Overall, the patients had a male majority (75.33%). The
mean age was 40 years (41 years for male, 38 years for
female) (range: 18–86 years). Most patients acquired
HIV through sexual contact (74.42%).
Immunologic status of newly diagnosed HIV/AIDS
patients
Table 1 and Figure 1 show the immunologic status of
newly diagnosed HIV/AIDS patients. The median CD4
count at HIV diagnosis was 83 cells/mm3 (IQR, 24–220)
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Table 1 Basic characteristics of study HIV/AIDS patients in China (n)
Characteristics Total Guangdong Guangxi Henan Heilongjiang Hunan Jiangxi Shaanxi Shanghai Xinjiang Yunnan
Number of patients 2866 197 1048 51 80 176 64 95 404 222 529
Age, years
18–24 131 20 33 3 5 15 4 9 23 3 16
25–34 941 91 303 11 29 50 16 33 115 98 195
35–44 911 53 301 26 22 60 23 32 114 100 180
45–54 463 18 185 7 14 29 13 14 90 16 77
≥55 420 15 226 4 10 22 8 7 62 5 61
Mean age 40 35 43 40 39 39 41 37 41 36 40
Sex
Male 2159 144 799 34 64 111 50 70 362 177 348
Female 707 53 249 17 16 65 14 25 42 45 181
HIV transmission category
Sexual contact 2133 171 936 6 53 119 63 68 330 46 341
IDU 454 8 92 0 3 41 0 7 6 166 131
Blood transfusion 81 3 0 29 17 3 0 12 7 3 7
Unknown 198 15 20 16 7 13 1 8 61 7 50
CD4 count, cells/mm3
<100 1547 69 738 37 40 63 49 17 224 65 245
≥100 1319 128 310 14 40 113 15 78 180 157 284
Median CD4 count 83 159 37 51 101 172 42 285 79 183 112
Ethnicity
Han 1998 194 444 50 79 176 63 95 401 21 475
Zhuang 593 0 590 0 0 0 0 0 0 0 3
Uygur 183 0 0 0 0 0 0 0 1 181 1
Other 92 3 14 1 1 0 1 0 2 20 50
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Figure 1 The distribution of CD4 counts in newly diagnosed HIV-infected patients in China by province.
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(range: 1–926 cells/mm3), and the mean was 138 cells/mm3.
Among the 2866 patients, patients with a CD4 count of <50,
50 to 199, 200 to 349, 350 to 499, and ≥500 cells/mm3
accounted for 40.06%, 31.93%, 19.26%, 5.96% and 2.79%,
respectively. The patients with CD4 count ≤200 cells/mm3
accounted for 72.02%, whereas 53.98% of the patients had
a CD4 count that was <100 cells/mm3, and only 8.75% of
the patients had a CD4 count that was ≥350 cells/mm3.
Immunologic status of HIV/AIDS patients in different
provinces
The median CD4 counts of HIV/AIDS patients at diag-
nosis in 10 provinces are listed in Table 1. The CD4
counts at HIV diagnosis differed significantly according
to province (P<0.001). The highest and lowest median
CD4 counts of patients were found in Shaanxi and
Guangxi province, respectively. The proportion of pa-
tients with a CD4 count of <100 cells/mm3 at HIV diag-
nosis were: Guangdong 35.03%, Guangxi 70.42%, Henan
72.55%, Heilongjiang 50.00%, Hunan 35.80%, Jiangxi
76.56%, Shaanxi 17.90%, Shanghai 55.45%, Xinjiang
29.28% and Yunnan 46.31%. The distribution of CD4
counts at HIV diagnosis in HIV/AIDS patients in differ-
ent provinces is shown in Figure 1.
Immunologic status of HIV/AIDS patients according to sex
and age
Table 2 describes the median CD4 counts among HIV/
AIDS patients. The median CD4 counts in male and fe-
male patients were 81 cells/mm3 and 97 cells/mm3, re-
spectively. The difference in CD4 counts between males
and females was not statistically significant (P=0.469).
The CD4 count at HIV diagnosis differed significantly
according to age (P=0.002), the median CD4 count was
highest in patients who were 18 to 24 years of age.
Immunologic status of HIV/AIDS patients according to
ethnicity
The CD4 counts at HIV diagnosis differed significantly
according to ethnicity (P<0.001); the highest and lowest
median CD4 count were found in Uygur and Zhuang
patients, respectively (Table 2). The distribution of CD4
counts in HIV/AIDS patients with different ethnicities is
shown in Figure 2.
Immunologic status of HIV/AIDS patients with different
routes of HIV transmission
The median CD4 counts in HIV patients with different
routes of HIV transmission are shown in Table 2. The
CD4 count at HIV diagnosis differed significantly according
to HIV transmission route (P<0.001), the median CD4
count in patients infected with HIV through intravenous
drug use was highest (Figure 3).
Identification of factors associated with low CD4 count at
HIV diagnosis
In a multivariate analysis using a multivariate logistic re-
gression model, we analyzed factors (including province,
sex, age, ethnicity, HIV transmission route) associated
with low CD4 count at HIV diagnosis. Table 3 summa-
rizes the results of the final regression model. In multi-
variate analysis, factors significantly associated with a
lower odds of low CD4 count at HIV diagnosis included
HIV transmission route classified as intravenous drug
use, older age, and having been diagnosed in Shaanxi
province. Factors associated with greater odds of low
CD4 count at HIV diagnosis included male sex, HIV
transmission route classified as unknown transmission
risk, having been diagnosed in provinces Guangxi,
Henan, Heilongjiang, Jiangxi, Shanghai and Yunnan.
Ethnicity failed to show an association with low CD4
count at HIV diagnosis.
Discussion
The results of the current study reveal that the majority
of newly diagnosed HIV positive patients in China had
Table 2 The median CD4 counts among study HIV/AIDS
patients

















P value for difference# <0.001
HIV transmission category
Sexual contact 67(21, 202)
Intravenous drug use 163(64, 271)
Blood transfusion 98(32, 209)
Unknown transmission risk 70(25, 205)
P value for difference# <0.001
NOTE: * Mann–Whitney U test was uesd; # Kruskal-Wallis H test was used.
Shen et al. BMC Infectious Diseases 2013, 13:429 Page 4 of 8
http://www.biomedcentral.com/1471-2334/13/429
an initial CD4 count consistent with an AIDS diagnosis.
The initial CD4 counts of the majority of the patients were
already in the range requiring commencement of ART.
The results reflect a significant delay in the diagnosis of
HIV-infected patients. This delay may compromise early
management of HIV-infected individuals and enhances
propagation of the epidemic in China.
Prior studies also suggest that a significant proportion
of newly diagnosed HIV-infected patients in China are







Total Han Zhuang Uygur Other ethnicity
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Figure 2 The distribution of CD4 counts in newly diagnosed HIV-infected patients in China by ethnicity.
Figure 3 The CD4 counts in newly diagnosed HIV/AIDS patients with different routes of HIV transmission in China (1: sexual contact, 2:
blood transfusion, 3: intravenous drug use, 4: unknown transmission risk. Each box shows the median, quartiles, and the extreme values
within a category) (N: sample size of the group).
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investigation [11] conducted in Yunnan and Guangxi
showed that the overall median CD4 cell count of the
newly identified HIV and AIDS cases in years 2005 to
2009 was 285 cells/mm3, and 63% of the patients had
CD4 counts <350 cells/mm3. Another study [12] showed
that the median baseline CD4 cell count of all patients
in China national treatment database from June 2002-
August 2008 was 118 cells/mm3. These findings rein-
force results from our study, which show that there are
difficulties surrounding the early identification of HIV
cases in China.
The results of our study are comparable to some stud-
ies in other countries, which also indicate a delay in the
diagnosis of HIV infected patients. A study [13] carried
out between January 2006 and December 2008 showed
that 60.4% of the newly HIV diagnosed Moroccan
patients had CD4 counts <200 cells/mm3 when HIV
diagnosis was confirmed. A similar investigation [14]
conducted in Nigeria between January 2009 and March
2010 reported that 71.8% of the patients had a CD4
count <350 cells/mm3 at HIV diagnosis. A study in USA
in 2001 [15] showed that the mean CD4 count in HIV
patients was 246 cells/mm3, and the median was 152
cells/mm3. Therefore, earlier diagnosis of HIV-infected
patients is a big challenge for all countries, especially the
developing countries.
The main reasons for late diagnosis of HIV infection
may be low initiative towards HIV testing and the dis-
crimination and stigma attached to the infection [13]. A
late diagnosis may also be due to a relatively weak know-
ledge among medical staff towards HIV associated dis-
eases [13]. China currently provides free services of VCT
for the public. However, because the general public in
China still has a limited awareness of HIV/AIDS and
their active acceptance of VCT service needs to be im-
proved, most HIV infected patients do not know their
HIV status. More sustained and vigorous awareness cam-
paigns still need to be done to diagnose this disease early.
Moreover, continuing education in HIV/AIDS among
healthcare providers should also be reinforced.
We found that the median CD4 count at HIV diagno-
sis differed significantly according to age, ethnicity, HIV
transmission route and province. Although the reasons
for this finding remain unclear, it may reflect various fac-
tors including patient characteristics, the medical setting,
and factors related to reasons for HIV testing. A study
conducted in India [16] showed that there is a consider-
able variation in CD4 counts in the Indian population,
and that there exists regional diversity in the T-lymphocyte
subset counts. China is a country with a large territory
and an extremely large population. The difference in
CD4 counts in newly diagnosed HIV-infected patients
may reflect regional diversity in the T-lymphocyte sub-
set counts in China. Our study indicates the need to es-
tablish a national reference range for absolute counts in
healthy Chinese men and women.
In agreement with other studies [17-19], risk factors
for late-stage HIV disease presentation arose in diverse
domains of influence, including geographic, economic,
demographic, social, and psychosocial. In our sample,
males, younger people, people diagnosed in the prov-
inces Guangxi, Henan, Heilongjiang, Jiangxi, Shanghai
and Yunnan, and persons who acquired the infection
through unknown transmission route showed a higher
risk of low CD4 count at HIV diagnosis. These findings
provide focused targets for improving HIV testing pro-
grams in order to diagnose people earlier and reduce the
number of adults presenting to care with late-stage HIV
disease. Different strategies and measures should be
taken for different regions and populations to detect
HIV infection as early as possible.
Table 3 Identification of factors associated with low CD4
count at HIV diagnosis among newly diagnosed HIV/AIDS
patients in China, results of the multivariate logistic
regression
Factor* P value Odds ratio 95% confidence
interval
Age,per 10-year increment 0.012 0.911 (0.847, 0.980)
Male sex 0.017 1.258 (1.042, 1.518)
Ethnicity - - -
Han 0.280 1.000 -
Zhuang 0.726 0.944 (0.683, 1.303)
Uygur 0.060 2.004 (0.971, 4.134)
Other 0.808 1.065 (0.643, 1.763)
HIV transmission route - - -
Sexual contact <0.001 1.000 -
Blood transfusion 0.765 1.088 (0.624, 1.898)
Intravenous drug use <0.001 0.524 (0.405, 0.677)
Unknown transmission risk 0.01 1.518 (1.104, 2.088)
Province
Guangdong <0.001 1.000 -
Guangxi <0.001 5.016 (3.608, 6.972)
Henan <0.001 4.414 (2.064, 9.440)
Heilongjiang 0.025 1.857 (1.080, 3.193)
Hunan 0.340 1.235 (0.801, 1.903)
Jiangxi <0.001 6.362 (3.314, 12.210)
Shaanxi 0.004 0.409 (0.223, 0.750)
Shanghai <0.001 2.251 (1.574, 3.219)
Xinjiang 0.388 1.219 (0.778, 1.909)
Yunnan <0.001 1.916 (1.353, 2.713)
NOTE: *P values of the likelihood ratio test for age, sex, ethnicity, HIV
transmission route and province were 0.012, 0.017, 0.850, <0.001 and <0.001,
respectively.
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The finding that patients reported in the provinces of
Guangxi, Henan, Heilongjiang, Jiangxi, Shanghai and
Yunnan were more likely to have low CD4 count at HIV
diagnosis, suggests a poorer access to HIV testing centers
or a lower risk perception of HIV infection. Increased
efforts should be made to identify new cases of HIV in-
fection in these provinces.
In keeping with other reports [17], males were more
likely to be diagnosed later in infection than females,
and intravenous drug users were associated with lower
risks of late presentation. The lower proportion of fe-
males being diagnosed late can be attributed to a higher
uptake of VCT services by the females as part of routine
health care services during pregnancy [17]. The known
high risk of HIV infection in intravenous drug users
means that clinicians are often more active in providing
HIV testing for this group and this may result in earlier
patient detection. Homosexual transmission route has
been reported to be associated with a lesser risk of late
presentation in previous studies [18,20], this finding may
be associated with a higher probability among MSM
(men who have sex with men) of undergoing HIV test-
ing which reflects a higher perception of sexual risk
behavior. In our study, we could not analyze the associ-
ation between homosexual or heterosexual transmission
route and low CD4 count because the data on homosex-
ual sex were not available. This may lead to ignorance of
such important risk factor and subsequently under
prioritize intervention in this special group. Our finding
that unknown HIV transmission route and younger age
were associated with a higher risk of low CD4 count
may be associated with a lower probability among these
populations of undergoing HIV testing. A study [21]
from San Francisco showed that late HIV testing was
more likely among persons <30 years old, heterosexuals,
and persons without a reported risk.
There are some notable limitations to this study. First,
potential sample selection bias may have affected the
findings. The HIV epidemic is serious in some areas and
among some most-at-risk populations in China, hence
the study population is not representative of the entire
newly diagnosed HIV positive population in China and
so the results may not be generalizable. Second, the de-
sign of the study was observational, we were able to
examine potential associations but were unable to assess
causation. Third, we did not assess some factors (cul-
tural, psychological, socioeconomic) shown to be associ-
ated with low CD4 count in other studies [19]. Further
studies assessing the role of other factors may help un-
derstanding the cause of late HIV diagnosis, and should
be undertaken to improve the management of HIV in-
fection in China. Fourth, inaccuracy and incompleteness
of documentation in the patients' medical histories, as
well as variation in equipment and techniques used by
different provinces to analyze the CD4 counts might
have decreased the accuracy of our data or introduced
biases.
Conclusions
At the time of HIV diagnosis, a large proportion of HIV-
infected patients in China had an initial CD4 count that
was consistent with relatively advanced disease. Males,
younger people, people diagnosed in provinces Guangxi,
Henan, Heilongjiang, Jiangxi, Shanghai and Yunnan, and
persons who acquired the infection through unknown
transmission route showed a higher risk of low CD4
count at HIV diagnosis. These results reinforce the im-
portance of identifying HIV infection as early as possible
and suggest the need for a more active offer of HIV testing
in these populations.
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